| | | | | | | Sponsored | Our Novaplex™ respiratory panel assays can test for the most prevalent respiratory pathogens including bacteria and viruses, across multiple sample types. For research use only. |
|
|
|
| |
| | |
|
|
| | | | | | Because low-risk prostate cancer is unlikely to spread or impact survival, experts and guidelines recommend active surveillance, which involves regular monitoring and thus avoid or delay treatment like surgery or radiation therapy and their life-changing complications. |
|
|
|
| |
| | |
|
|
| | | | | | New research by investigators from the Department of Psychiatry and Behavioral Neurosciences at Cedars-Sinai shows that behavioral activation therapy is as effective as antidepressant medications in treating symptoms of depression in patients with heart failure. |
|
|
|
| |
| | |
|
|
| | | | | | In a new study, researchers wanted to know whether blood-brain barrier impairment contributed to the development of neurological problems during COVID-19 progression, and to what extent. |
|
|
|
| |
| | |
|
|
| | | | Sponsored | | New vaccines and diagnostic developments have heightened the interest in RSV prevention and testing. In this webinar, pediatric, adult, and public health specialists discuss RSV epidemiology, vulnerable populations, lack of testing, multiplex diagnostics, and respiratory virus symptom overlap. |
|
|
|
| |
| | |
|
|
| | | | | | Scientists at La Jolla Institute for Immunology (LJI) have published an in-depth study into how the immune system’s T cells target pediatric brain tumors. Their research suggests that a small number of pediatric brain tumor patients already have cancer-fighting T cells within their tumors. |
|
|
|
| |
| | |
|
|
| | | | Sponsored | | Tosoh G8 HbA1c analyzer can now be connected to the Sysmex XN-9000™ and XN-9100™ automated hematology systems in the U.S., Latin America and Canada. With this agreement, Tosoh Bioscience aims to expand its HbA1c offering to the high-volume testing market and further automate hemoglobin A1c testing. |
|
|
|
| |
| | |
|
|
| | | | | | Rutgers researchers can predict which patients will benefit from a popular prostate cancer drug – and have devised a strategy that may make the treatment work longer. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
